Baird Financial Group’s Cognition Therapeutics CGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-22,393
| Closed | -$37.2K | – | 1758 |
|
|
2024
Q2 | $37.2K | Hold |
22,393
| – | – | ﹤0.01% | 1739 |
|
|
2024
Q1 | $40.8K | Hold |
22,393
| – | – | ﹤0.01% | 1737 |
|
|
2023
Q4 | $41.4K | Hold |
22,393
| – | – | ﹤0.01% | 1692 |
|
|
2023
Q3 | $32.2K | Hold |
22,393
| – | – | ﹤0.01% | 1691 |
|
|
2023
Q2 | $41K | Hold |
22,393
| – | – | ﹤0.01% | 1672 |
|
|
2023
Q1 | $44.3K | Buy |
22,393
+2,300
| +11% | +$4.55K | ﹤0.01% | 1670 |
|
|
2022
Q4 | $42K | Sell |
20,093
-20,693
| -51% | -$43.3K | ﹤0.01% | 1668 |
|
|
2022
Q3 | $77K | Buy |
40,786
+20,393
| +100% | +$38.5K | ﹤0.01% | 1679 |
|
|
2022
Q2 | $43K | Hold |
20,393
| – | – | ﹤0.01% | 1756 |
|
|
2022
Q1 | $56K | Buy |
+20,393
| New | +$56K | ﹤0.01% | 1785 |
|